(Q45358893)

English

H5N1 influenza virus-like particles produced by transient expression in mammalian cells induce humoral and cellular immune responses in mice

scientific article published on 19 March 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

H5N1 influenza virus-like particles produced by transient expression in mammalian cells induce humoral and cellular immune responses in mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

author name string

Ling Tao

1

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Jianjun Chen

2

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Zhenhua Zheng

3

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Jin Meng

4

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Zhenfeng Zhang

5

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Yao Chen

6

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Huanle Luo

7

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Hongxia Li

8

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Ze Chen

9

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Qinxue Hu

10

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Hanzhong Wang

11

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

publication date

19 March 2012

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Canadian Journal of Microbiology

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

58

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

391-401

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial.

1 reference

https://api.crossref.org/works/10.1139%2FW2012-006

21 January 2018

Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin

1 reference

https://api.crossref.org/works/10.1139%2FW2012-006

21 January 2018

Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle

1 reference

https://api.crossref.org/works/10.1139%2FW2012-006

21 January 2018

Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation

1 reference

https://api.crossref.org/works/10.1139%2FW2012-006

21 January 2018

Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles

1 reference

https://api.crossref.org/works/10.1139%2FW2012-006

21 January 2018

Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus

1 reference

https://api.crossref.org/works/10.1139%2FW2012-006

21 January 2018

Elicitation of protective immune responses using a bivalent H5N1 VLP vaccine.

1 reference

https://api.crossref.org/works/10.1139%2FW2012-006

21 January 2018

Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization

1 reference

https://api.crossref.org/works/10.1139%2FW2012-006

21 January 2018

Retroviral vectors pseudotyped with severe acute respiratory syndrome coronavirus S protein

1 reference

https://api.crossref.org/works/10.1139%2FW2012-006

21 January 2018

H5N1 influenza: a protean pandemic threat

1 reference

https://api.crossref.org/works/10.1139%2FW2012-006

21 January 2018

Influenza-pseudotyped Gag virus-like particle vaccines provide broad protection against highly pathogenic avian influenza challenge

1 reference

https://api.crossref.org/works/10.1139%2FW2012-006

21 January 2018

Comparative analysis of the immunogenicity of SARS-CoV nucleocapsid DNA vaccine administrated with different routes in mouse model

1 reference

https://api.crossref.org/works/10.1139%2FW2012-006

21 January 2018

Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza

1 reference

https://api.crossref.org/works/10.1139%2FW2012-006

21 January 2018

Engineering N-glycosylation pathways in the baculovirus-insect cell system

1 reference

https://api.crossref.org/works/10.1139%2FW2012-006

21 January 2018

Influenza virus-like particles as pandemic vaccines

1 reference

https://api.crossref.org/works/10.1139%2FW2012-006

21 January 2018

Induction of long-term protective immune responses by influenza H5N1 virus-like particles.

1 reference

https://api.crossref.org/works/10.1139%2FW2012-006

21 January 2018

Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults.

1 reference

https://api.crossref.org/works/10.1139%2FW2012-006

21 January 2018

Host cell proteases controlling virus pathogenicity

1 reference

https://api.crossref.org/works/10.1139%2FW2012-006

21 January 2018

Activation of influenza A viruses by trypsin treatment

1 reference

https://api.crossref.org/works/10.1139%2FW2012-006

21 January 2018

Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins

1 reference

https://api.crossref.org/works/10.1139%2FW2012-006

21 January 2018

Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses

1 reference

https://api.crossref.org/works/10.1139%2FW2012-006

21 January 2018

Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1139%2FW2012-006

21 January 2018

Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses.

1 reference

https://api.crossref.org/works/10.1139%2FW2012-006

21 January 2018

Humoral and cellular immune responses induced by 3a DNA vaccines against severe acute respiratory syndrome (SARS) or SARS-like coronavirus in mice

1 reference

https://api.crossref.org/works/10.1139%2FW2012-006

21 January 2018

Effect of mucosal and systemic immunization with virus-like particles of severe acute respiratory syndrome coronavirus in mice

1 reference

https://api.crossref.org/works/10.1139%2FW2012-006

21 January 2018

H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses.

1 reference

https://api.crossref.org/works/10.1139%2FW2012-006

21 January 2018

Plasmid-driven formation of influenza virus-like particles

1 reference

https://api.crossref.org/works/10.1139%2FW2012-006

21 January 2018

Novel type II transmembrane serine proteases, MSPL and TMPRSS13, Proteolytically activate membrane fusion activity of the hemagglutinin of highly pathogenic avian influenza viruses and induce their multicycle replication

1 reference

https://api.crossref.org/works/10.1139%2FW2012-006

21 January 2018

Avian influenza virus (H5N1): a threat to human health.

1 reference

https://api.crossref.org/works/10.1139%2FW2012-006

21 January 2018

Gastrointestinal delivery of baculovirus displaying influenza virus hemagglutinin protects mice against heterologous H5N1 infection.

1 reference

https://api.crossref.org/works/10.1139%2FW2012-006

21 January 2018

Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus.

1 reference

https://api.crossref.org/works/10.1139%2FW2012-006

21 January 2018

Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin

1 reference

https://api.crossref.org/works/10.1139%2FW2012-006

21 January 2018

Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin

1 reference

https://api.crossref.org/works/10.1139%2FW2012-006

21 January 2018

Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin.

1 reference

https://api.crossref.org/works/10.1139%2FW2012-006

21 January 2018

Role of hemagglutinin cleavage for the pathogenicity of influenza virus.

1 reference

https://api.crossref.org/works/10.1139%2FW2012-006

21 January 2018

Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness

1 reference

https://api.crossref.org/works/10.1139%2FW2012-006

21 January 2018

Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics.

1 reference

https://api.crossref.org/works/10.1139%2FW2012-006

21 January 2018

The influence of the multi-basic cleavage site of the H5 hemagglutinin on the attenuation, immunogenicity and efficacy of a live attenuated influenza A H5N1 cold-adapted vaccine virus

1 reference

https://api.crossref.org/works/10.1139%2FW2012-006

21 January 2018

Induction of neutralising antibodies by virus-like particles harbouring surface proteins from highly pathogenic H5N1 and H7N1 influenza viruses

1 reference

https://api.crossref.org/works/10.1139%2FW2012-006

21 January 2018

Establishment of retroviral pseudotypes with influenza hemagglutinins from H1, H3, and H5 subtypes for sensitive and specific detection of neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1139%2FW2012-006

21 January 2018

Characterization of lentiviral pseudotypes with influenza H5N1 hemagglutinin and their performance in neutralization assays.

1 reference

https://api.crossref.org/works/10.1139%2FW2012-006

21 January 2018

Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines.

1 reference

https://api.crossref.org/works/10.1139%2FW2012-006

21 January 2018

Mammalian expression of virus-like particles for advanced mimicry of authentic influenza virus

1 reference

https://api.crossref.org/works/10.1139%2FW2012-006

21 January 2018

Identifiers

10.1139/W2012-006

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45358893&oldid=2075807534"